FSSAI orders nationwide crackdown on illegal use of industrial dye Auramine in food products

States and UTs directed to conduct inspections, sampling and enforcement actions within 15 days; defaulting food businesses to face strict penalties under Food Safety Act.

The Food Safety and Standards Authority of India (FSSAI) has issued a nationwide enforcement order directing State and Union Territory food safety commissioners to initiate strict action against the illegal use of Auramine, an industrial dye, in roasted chana and other food products. The directive follows multiple complaints that the chemical—commonly used in textiles and leather processing—is being added to food items to enhance colour.

FSSAI cracks down on misleading ‘100% natural’ claims in food advertising

Dated November 28, 2025, the order states that Auramine is a non-permitted synthetic food colour under the Food Safety and Standards (Food Product Standards and Food Additives) Regulations, 2011. The presence of the dye in any food renders the product unsafe under Section 3(1)(zz)(v) of the Food Safety and Standards Act, 2006.

Crackdown and Enforcement Measures

FSSAI has ordered targeted enforcement actions, including:

* Inspections and surveillance across manufacturing, processing, storage, distribution and retail points

* Sampling and laboratory testing of roasted chana and other vulnerable food products

* Strict action against defaulting Food Business Operators (FBOs) in both organised and unorganised sectors, including those selling via e-commerce platforms

All Commissioners of Food Safety and Central Licensing Authorities have been instructed to begin immediate action and submit a consolidated Action Taken Report (ATR) within 15 days, as per the required format in Annexure A.

Testing Infrastructure and Accountability

The order includes a list of laboratories equipped to test for Auramine (Annexure B), ensuring standardised and traceable testing procedures nationwide.

FSSAI tightens compliance: FBOs must submit closure reports after license expiry

The directive was issued with the approval of the competent authority under Section 16(5) of the Food Safety and Standards Act, 2006, and signed by Dr. Satyen Kumar Panda, Executive Director (Compliance Strategy), FSSAI.

Copies of the order have been circulated to senior officials including the FSSAI Chairperson and CEO, as well as Regional Directors.

Related Posts

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

New Delhi: Serious legal gaps in the Drugs and Cosmetics Act, 1940, combined with acute shortages of manpower and infrastructure, continue to impede the Central Drugs Standard Control Organisation (CDSCO)…

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna: In a significant ruling that could have far-reaching implications for NDPS drug-related prosecutions involving common pharmaceutical compounds, the Patna High Court has held that Phenothiazine and Promethazine do not…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines